|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu P, Vernooy SY, Guo M and Hay BA: The
Drosophila microRNA Mir-14 suppresses cell death and is required
for normal fat metabolism. Curr Biol. 13:790–795. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weitz J, Koch M, Debus J, Hohler T, Galle
PR and Buchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lynch HT and de la Chapelle A: Hereditary
colorectal cancer. N Engl J Med. 348:919–932. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pagliuca A, Valvo C, Fabrizi E, et al:
Analysis of the combined action of miR-143 and miR-145 on oncogenic
pathways in colorectal cancer cells reveals a coordinate program of
gene repression. Oncogene. 32:4806–4813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prueitt RL, Yi M, Hudson RS, et al:
Expression of microRNAs and protein-coding genes associated with
perineural invasion in prostate cancer. Prostate. 68:1152–1164.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mavridis K, Stravodimos K and Scorilas A:
Downregulation and prognostic performance of microRNA 224
expression in prostate cancer. Clin Chem. 59:261–269. 2013.
View Article : Google Scholar
|
|
9
|
Huang L, Dai T, Lin X, et al: MicroRNA-224
targets RKIP to control cell invasion and expression of metastasis
genes in human breast cancer cells. Biochem Biophys Res Commun.
425:127–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
White NM, Chow TF, Mejia-Guerrero S, et
al: Three dysregulated miRNAs control kallikrein 10 expression and
cell proliferation in ovarian cancer. Br J Cancer. 102:1244–1253.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen SN, Wang LF, Jia YF, Hao YQ, Zhang L
and Wang H: Upregulation of microRNA-224 is associated with
aggressive progression and poor prognosis in human cervical cancer.
Diagn Pathol. 8:692013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mees ST, Mardin WA, Sielker S, et al:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Lee AT, Ma JZ, et al: Profiling
microRNA expression in hepatocellular carcinoma reveals
microRNA-224 up-regulation and apoptosis inhibitor-5 as a
microRNA-224-specific target. J Biol Chem. 283:13205–13215. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ladeiro Y, Couchy G, Balabaud C, et al:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Wang G, Shan JL, et al: MicroRNA-224
is upregulated in HepG2 cells and involved in cellular migration
and invasion. J Gastroenterol Hepatol. 25:164–171. 2010. View Article : Google Scholar
|
|
16
|
Arndt GM, Dossey L, Cullen LM, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vega AB, Pericay C, Moya I, et al:
microRNA expression profile in stage III colorectal cancer:
Circulating miR-18a and miR-29a as promising biomarkers. Oncol Rep.
30:320–326. 2013.
|
|
18
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nikiforova MN, Tseng GC, Steward D, Diorio
D and Nikiforov YE: MicroRNA expression profiling of thyroid
tumors: biological significance and diagnostic utility. J Clin
Endocrinol Metab. 93:1600–1608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu S, Wang S, Geng S, Ma S, Liang Z and
Jiao B: Upregulation of microRNA-224 confers a poor prognosis in
glioma patients. Clin Transl Oncol. 15:569–574. 2013. View Article : Google Scholar
|
|
21
|
Li Z, Lu J, Sun M, et al: Distinct
microRNA expression profiles in acute myeloid leukemia with common
translocations. Proc Natl Acad Sci USA. 105:15535–15540. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rigou P, Piddubnyak V, Faye A, et al: The
antiapoptotic protein AAC-11 interacts with and regulates
Acinus-mediated DNA fragmentation. EMBO J. 28:1576–1588. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koci L, Chlebova K, Hyzdalova M, et al:
Apoptosis inhibitor 5 (API-5; AAC-11; FIF) is upregulated in human
carcinomas in vivo. Oncol Lett. 3:913–916. 2012.PubMed/NCBI
|
|
24
|
Koelzer VH, Karamitopoulou E, Dawson H,
Kondi-Pafiti A, Zlobec I and Lugli A: Geographic analysis of RKIP
expression and its clinical relevance in colorectal cancer. Br J
Cancer. 108:2088–2096. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chatzigeorgiou A, Lyberi M, Chatzilymperis
G, Nezos A and Kamper E: CD40/CD40L signaling and its implication
in health and disease. Biofactors. 35:474–483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Georgopoulos NT, Merrick A, Scott N, Selby
PJ, Melcher A and Trejdosiewicz LK: CD40-mediated death and
cytokine secretion in colorectal cancer: a potential target for
inflammatory tumour cell killing. Int J Cancer. 121:1373–1381.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagtegaal ID, Quirke P and Schmoll HJ: Has
the new TNM classification for colorectal cancer improved care?
Nature reviews Clin Oncol. 9:119–123. 2012. View Article : Google Scholar
|
|
28
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
30
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: a new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chung DC: The genetic basis of colorectal
cancer: insights into critical pathways of tumorigenesis.
Gastroenterology. 119:854–865. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Colussi D, Brandi G, Bazzoli F and
Ricciardiello L: Molecular pathways involved in colorectal cancer:
implications for disease behavior and prevention. Int J Mol Sci.
14:16365–16385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan Y, Zhang B, Wu T, et al:
Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human
breast cancer cells. BMC Mol Biol. 10:122009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hawkins PG and Morris KV: RNA and
transcriptional modulation of gene expression. Cell Cycle.
7:602–607. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mlcochova J, Faltejskova P, Nemecek R,
Svoboda M and Slaby O: MicroRNAs targeting EGFR signalling pathway
in colorectal cancer. J Cancer Res Clin Oncol. 139:1615–1624. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma Q, Wang X, Li Z, et al: microRNA-16
represses colorectal cancer cell growth in vitro by regulating the
p53/survivin signaling pathway. Oncol Rep. 29:1652–1658.
2013.PubMed/NCBI
|
|
38
|
Ma Y, Li W and Wang H: Roles of miRNA in
the initiation and development of colorectal carcinoma. Curr Pharm
Des. 19:1253–1261. 2013.
|
|
39
|
Yamada N, Noguchi S, Mori T, Naoe T, Maruo
K and Akao Y: Tumor-suppressive microRNA-145 targets catenin
delta-1 to regulate Wnt/beta-catenin signaling in human colon
cancer cells. Cancer Lett. 335:332–342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu J, Tang W, Du P, et al: Identifying
microRNA-mRNA regulatory network in colorectal cancer by a
combination of expression profile and bioinformatics analysis. BMC
Syst Biol. 6:682012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nagel R, le Sage C, Diosdado B, et al:
Regulation of the adenomatous polyposis coli gene by the miR-135
family in colorectal cancer. Cancer Res. 68:5795–5802. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu Y, Kanwar SS, Patel BB, et al:
MicroRNA-21 induces stemness by downregulating transforming growth
factor beta receptor 2 (TGFbetaR2) in colon cancer cells.
Carcinogenesis. 33:68–76. 2012. View Article : Google Scholar :
|
|
43
|
Dong Y, Wu WK, Wu CW, Sung JJ, Yu J and Ng
SS: MicroRNA dysregulation in colorectal cancer: a clinical
perspective. Br J Cancer. 104:893–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhai H and Ju J: Implications of microRNAs
in colorectal cancer development, diagnosis, prognosis, and
therapeutics. Front Genet. 2:pii00078. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Menendez P, Villarejo P, Padilla D,
Menendez JM and Rodriguez-Montes JA: Implications of the
histological determination of microRNAs in the screening, diagnosis
and prognosis of colorectal cancer. J Surg Oncol. 108:70–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schetter AJ and Harris CC: Alterations of
microRNAs contribute to colon carcinogenesis. Semin Oncol.
38:734–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Madhavan D, Cuk K, Burwinkel B and Yang R:
Cancer diagnosis and prognosis decoded by blood-based circulating
microRNA signatures. Front Genet. 4:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bartley AN, Yao H, Barkoh BA, et al:
Complex patterns of altered MicroRNA expression during the
adenoma-adenocarcinoma sequence for microsatellite-stable
colorectal cancer. Clin Cancer Res. 17:7283–7293. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kalimutho M, Del Vecchio Blanco G, Di
Cecilia S, et al: Differential expression of miR-144* as
a novel fecal-based diagnostic marker for colorectal cancer. J
Gastroenterol. 46:1391–1402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xiao YF, Yong X, Fan YH, Lu MH, Yang SM
and Hu CJ: microRNA detection in feces, sputum, pleural effusion
and urine: Novel tools for cancer screening (Review). Oncol Rep.
30:535–544. 2013.PubMed/NCBI
|
|
51
|
Wu CW, Ng SS, Dong YJ, et al: Detection of
miR-92a and miR-21 in stool samples as potential screening
biomarkers for colorectal cancer and polyps. Gut. 61:739–745. 2012.
View Article : Google Scholar
|
|
52
|
Cho WC: Epigenetic alteration of microRNAs
in feces of colorectal cancer and its clinical significance. Expert
Rev Mol Diagn. 11:691–694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kalimutho M, Di Cecilia S, Del Vecchio
Blanco G, et al: Epigenetically silenced miR-34b/c as a novel
faecal-based screening marker for colorectal cancer. Br J Cancer.
104:1770–1778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Srivastava K and Srivastava A:
Comprehensive review of genetic association studies and
meta-analyses on miRNA polymorphisms and cancer risk. PLoS One.
7:e509662012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yao G, Yin M, Lian J, et al: MicroRNA-224
is involved in transforming growth factor-beta-mediated mouse
granulosa cell proliferation and granulosa cell function by
targeting Smad4. Mol Endocrinol. 24:540–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li X, Shen Y, Ichikawa H, Antes T and
Goldberg GS: Regulation of miRNA expression by Src and contact
normalization: effects on nonanchored cell growth and migration.
Oncogene. 28:4272–4283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang Y, Ren J, Gao Y, et al: MicroRNA-224
targets SMAD family member 4 to promote cell proliferation and
negatively influence patient survival. PLoS One. 8:e687442013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Miyaki M and Kuroki T: Role of Smad4
(DPC4) inactivation in human cancer. Biochem Biophys Res Commun.
306:799–804. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Al-Mulla F, Bitar MS, Taqi Z and Yeung KC:
RKIP: much more than Raf kinase inhibitory protein. J Cell Physiol.
228:1688–1702. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mencia N, Selga E, Noe V and Ciudad CJ:
Underexpression of miR-224 in methotrexate resistant human colon
cancer cells. Biochem Pharmacol. 82:1572–1582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Link A, Balaguer F, Shen Y, et al: Fecal
MicroRNAs as novel biomarkers for colon cancer screening. Cancer
Epidemiol Biomarkers Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cheng H, Zhang L, Cogdell DE, et al:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ng EK, Chong WW, Jin H, et al:
Differential expression of microRNAs in plasma of patients with
colorectal cancer: a potential marker for colorectal cancer
screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar
|
|
65
|
Yuan K, Xie K, Fox J, et al: Decreased
levels of miR-224 and the passenger strand of miR-221 increase
MBD2, suppressing maspin and promoting colorectal tumor growth and
metastasis in mice. Gastroenterology. 145:853–864. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hyslop T and Waldman SA: Molecular staging
of node negative patients with colorectal cancer. J Cancer.
4:193–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liao WT, Li TT, Wang ZG, et al:
microRNA-224 promotes cell proliferation and tumor growth in human
colorectal cancer by repressing PHLPP1 and PHLPP2. Clin Cancer Res.
19:4662–4672. 2013. View Article : Google Scholar : PubMed/NCBI
|
